Elevance Health Inc 1ANTM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
'I didn't know what else to do': Patients take their health-insurance battles to Facebook and LinkedIn
-
Health, Insurance Stocks Gain After Trump Administration Plans Higher Payments to Medicare Insurers
-
Health insurers secured a better Medicare Advantage rate for 2027, and their stocks are soaring
-
Stocks to Watch: Health Insurers, Mawson, Owlet
-
Health Insurance Shares Gain on 2.48% Medicare Rate Bump
-
It's not just patients who are sick of fighting health insurers. Doctors are frustrated, too.
-
Why shares of UnitedHealth, Humana and other insurers tanked - and took the Dow with them
-
Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate
Trading Information
- Previous Close Price
- €369.20
- Day Range
- €372.30–375.00
- 52-Week Range
- €244.10–400.40
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 216.87M
- Market Cap
- $81.61B
- Volume/Avg
- 5 / 5
Key Statistics
- Price/Earnings (Normalized)
- 14.94
- Price/Sales
- 0.48
- Dividend Yield (Trailing)
- 1.59%
- Dividend Yield (Forward)
- 1.61%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 4.42%
Company Profile
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Stock Style Box
- Mid Value
- Total Number of Employees
- 97,100
- Website
- https://www.elevancehealth.com
Competitors
Valuation
|
Metric
|
1ANTM
|
HUM
|
CI
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.94 | 25.20 | 9.00 |
Price/Book Value | 2.08 | 2.71 | 1.75 |
Price/Sales | 0.48 | 0.36 | 0.27 |
Price/Cash Flow | 16.06 | 18.90 | 7.47 |
Price/Earnings
1ANTM
HUM
CI
Financial Strength
|
Metric
|
1ANTM
|
HUM
|
CI
|
|---|---|---|---|
Quick Ratio | — | — | 0.68 |
Current Ratio | — | — | 0.85 |
Interest Coverage | 5.08 | 3.37 | 7.08 |
Quick Ratio
1ANTM
HUM
CI
Profitability
|
Metric
|
1ANTM
|
HUM
|
CI
|
|---|---|---|---|
Return on Assets (Normalized) | 5.24% | 3.18% | 5.37% |
Return on Equity (Normalized) | 14.71% | 9.02% | 20.03% |
Return on Invested Capital (Normalized) | 10.18% | 7.08% | 12.89% |
Return on Assets
1ANTM
HUM
CI
Healthcare Plans Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc
UNH
| LOCK|g<>sxw | LOCK|qpTzb | $340B | |||
| CVS Health Corp
CVS
| LOCK|gC@zx% | LOCK|vR | $112B | |||
| Elevance Health Inc
ELV
| LOCK|N???!&J | LOCK|Y>H# | $92B | |||
| The Cigna Group
CI
| LOCK|CRz>V> | LOCK|w^^& | $75B | |||
| Humana Inc
HUM
| LOCK|pw??GSJ | LOCK|W!p<Z | $52B | |||
| Centene Corp
CNC
| LOCK|q<hck> | LOCK|%<f | $33B | |||
| Molina Healthcare Inc
MOH
| LOCK|Rqkl>q# | LOCK|Ll!^> | $11B | |||
| Oscar Health Inc Class A
OSCR
| — | LOCK|v>b | $10B | |||
| Clover Health Investments Corp Ordinary Shares - Class A
CLOV
| — | LOCK|qt | $3B | |||
| Progyny Inc
PGNY
| — | LOCK|&r | $2B |
United States